Hypocretin-1 (orexin-A) produced changes in glutamate and GABA release: An in vivo microdialysis study.

被引：0
|
作者：
John, J
Wu, MF
Kodama, T
Siegel, JM
机构：
[1] Sepulveda VA Med Ctr, N Hills, CA 91343 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Psychiat, Los Angeles, CA 90024 USA
来源：
SLEEP | 2001年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
32
引用
收藏
页码：A20 / A20
页数：1
相关论文
共 50 条
  • [21] CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia
    Kanbayashi, T
    Inoue, Y
    Chiba, S
    Aizawa, R
    Saito, Y
    Tsukamoto, H
    Fujii, Y
    Nishino, S
    Shimizu, T
    [J]. JOURNAL OF SLEEP RESEARCH, 2002, 11 (01) : 91 - 93
  • [22] Decreased CSF hypocretin-1 (orexin-A) after acute haemorrhagic brain injury
    Rejdak, K
    Petzold, A
    Lin, L
    Smith, M
    Kitchen, N
    Thompson, EJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (04): : 597 - 598
  • [23] Orexin-A (hypocretin-1) levels in cerebrospinal fluid of patients with sleep and neurologic disorders
    Baumann, CR
    Maly, F
    Bischof, M
    Bassetti, CL
    [J]. SLEEP, 2003, 26 : A352 - A352
  • [24] CSF Levels of Hypocretin-1 (Orexin-A) Peak during Early Infancy in Humans
    Aran, Adi
    Shors, Irina
    Lin, Ling
    Mignot, Emmanuel
    Schimmel, Michael S.
    [J]. SLEEP, 2012, 35 (02) : 187 - 191
  • [25] CSF hypocretin-1 (OREXIN-A) measurement in pediatric and teenage patients with sleep disorders
    Arii, J.
    Kanbayashi, T.
    Hishikawa, Y.
    Shimizu, T.
    Maruyama, F.
    Narumi, A.
    Yano, T.
    Suda, H.
    Kaneko, Y.
    [J]. SLEEP, 2008, 31 : A218 - A218
  • [26] Hypocretin-1/Orexin-A and excessive daytime sleepiness in patients with nonconvulsive status epilepticus
    Slonkova, J.
    Togtokhjargal, A.
    Revendova, K. Zondra
    Plochova, M.
    Bartos, V.
    Hanzlikova, P.
    Volny, O.
    [J]. EPILEPSIA, 2023, 64 : 489 - 489
  • [27] CSF hypocretin-1 (orexin-A) measurement in pediatric and teenager patients with hypersomnia and/or cataplexy
    Kanbayashi, T
    Arii, J
    Kondo, H
    Ogawa, Y
    Aizawa, R
    Takemura, T
    Mishima, K
    Iijima, S
    Hishikawa, Y
    Shimizu, T
    [J]. SLEEP, 2004, 27 : 237 - 237
  • [28] The significance of CSF hypocretin-1 (Orexin-A) measurement in pediatric and adolescent neurologic disorders
    Arii, J
    Kanbayashi, T
    Sawaishi, Y
    Yano, T
    Kimura, S
    Hishikawa, Y
    Takahashi, Y
    Shimizu, Y
    Tanabe, Y
    Nishino, S
    [J]. SLEEP, 2003, 26 : A129 - A130
  • [29] The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy
    Weinhold, Sara Lena
    Seeck-Hirschner, Mareen
    Nowak, Alexander
    Hallschmid, Manfred
    Goeder, Robert
    Baier, Paul Christian
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2014, 262 : 8 - 13
  • [30] Orexin-A/hypocretin-1 microinjections into the ventromedial medulla facilitate muscle tone in decerebrate rats
    Kiyashchenko, LI
    Mileykovskiy, BY
    Siegel, JM
    [J]. SLEEP, 2001, 24 : A133 - A133
12345